2026-08-28
Suzhou Tianji Biopharmaceutical has received the Drug
Registration Certificate from China's National Medical
Products Administration (NMPA) for Cetrorelix Acetate for
Injection, 0.25 mg. The product is approved for marketing in China.
Cetrorelix is a GnRH antagonist used in assisted
reproduction — given during controlled ovarian
stimulation to prevent a premature LH surge.
It is a synthetic decapeptide, supplied as a lyophilized powder for injection.
